AZN.L
AstraZeneca PLC
LSE
4,692.0053.50 (1.15%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close4,638.50
Open4,662.50
Bid4,691.50 x 6100
Ask4,692.50 x 13000
52wk Range3,680.00 - 4,701.50
Day's Range4,640.00 - 4,698.50
Volume1,203,378
Avg Vol (3m)2,620,093
As of 9:54 AM EDT. LSE Delayed Price. Market open.
  • Market Realist1 hour ago

    Which Growth Platforms Will Drive AstraZeneca’s 2Q16 Earnings?

    AstraZeneca's (AZN) growth platforms include respiratory and diabetes products, Brilinta/Brilique, and regional sales from emerging markets and Japan.

  • Reuters6 hours ago

    GlaxoSmithKline invests $360 mln in UK despite Brexit vote

    GlaxoSmithKline plans 275 million pounds ($361 million) of new investments at three drug manufacturing sites in Britain, signalling its confidence in the country despite last month's vote to leave the European Union. Britain's biggest drugmaker, which had argued against Brexit before the referendum, believes the UK remains an attractive place for making medicines, thanks to a skilled workforce and relatively low tax rates. "It is testament to our skilled UK workforce and the country's leading position in life sciences that we are making these investments in advanced manufacturing here," said Chief Executive Andrew Witty.